| Amir Habib, MD | |
|
3500 S Lafountain St, Kokomo, IN 46902-3803 | |
| (765) 453-8090 | |
| Not Available |
| Full Name | Amir Habib |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 29 Years |
| Location | 3500 S Lafountain St, Kokomo, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306889233 | NPI | - | NPPES |
| 200378840 | Medicaid | IN | |
| P00425746 | Other | IN | RAILROAD |
| P01824442 | Other | IN | RAILROAD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 01055657A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Indiana University Health | Indianapolis, IN | Hospital |
| Major Hospital | Shelbyville, IN | Hospital |
| Iu Health West Hospital | Avon, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Indiana Clinic Critical Care Llc | 3678600988 | 206 |
| Major Hospital | 0446167415 | 77 |
News Archive
Huntington's disease (HD) is a fatal hereditary disease for which there is no cure. A novel study from Cedars-Sinai Medical Center, Los Angeles, using pluripotent stem cells advances understanding of how the disease develops and may help pave the way for identifying pathways for future treatments.
Barr Pharmaceuticals, Inc. has announced that the U.S. District Court for the District of New Jersey has ruled in favor of its subsidiary, Barr Laboratories, Inc., in the challenge of the patent listed by Bayer Schering Pharma, AG in connection with Bayer Schering's Yasmin(R) (drospirenone and ethinyl estradiol) oral contraceptive.
JP Errico, founder and CEO of electroCore, speaking at The FT Global Pharmaceutical and Biotechnology Conference in London last week, emphasized the importance of working with each of the major stakeholders, i.e., patients and their advocates, key opinion-leading physicians, and decision-makers within the payor community at the earliest opportunity, particularly in regards to innovative and disruptive technology such as electroCore's non-invasive vagus nerve stimulation (nVNS).
A study on the effects of donepezil on people with mild to moderate Alzheimer Disease entitled Long-term donepezil treatment in 565 patients with Alzheimer's Disease(AD2000): randomised double-blind trial appears in the June 26, 2004 issue of The Lancet.
University of Maryland School of Nursing researchers say nurses in hospitals and other health care facilities may perform better by following the lead of airlines, trucking, and nuclear plants, by limiting hours of service, ensuring prompt and definite breaks during shifts, and other scheduling strategies.
› Verified 7 days ago
| Entity Name | Major Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174555692 PECOS PAC ID: 0446167415 Enrollment ID: O20040108000586 |
News Archive
Huntington's disease (HD) is a fatal hereditary disease for which there is no cure. A novel study from Cedars-Sinai Medical Center, Los Angeles, using pluripotent stem cells advances understanding of how the disease develops and may help pave the way for identifying pathways for future treatments.
Barr Pharmaceuticals, Inc. has announced that the U.S. District Court for the District of New Jersey has ruled in favor of its subsidiary, Barr Laboratories, Inc., in the challenge of the patent listed by Bayer Schering Pharma, AG in connection with Bayer Schering's Yasmin(R) (drospirenone and ethinyl estradiol) oral contraceptive.
JP Errico, founder and CEO of electroCore, speaking at The FT Global Pharmaceutical and Biotechnology Conference in London last week, emphasized the importance of working with each of the major stakeholders, i.e., patients and their advocates, key opinion-leading physicians, and decision-makers within the payor community at the earliest opportunity, particularly in regards to innovative and disruptive technology such as electroCore's non-invasive vagus nerve stimulation (nVNS).
A study on the effects of donepezil on people with mild to moderate Alzheimer Disease entitled Long-term donepezil treatment in 565 patients with Alzheimer's Disease(AD2000): randomised double-blind trial appears in the June 26, 2004 issue of The Lancet.
University of Maryland School of Nursing researchers say nurses in hospitals and other health care facilities may perform better by following the lead of airlines, trucking, and nuclear plants, by limiting hours of service, ensuring prompt and definite breaks during shifts, and other scheduling strategies.
› Verified 7 days ago
| Entity Name | Indiana Clinic Critical Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417285230 PECOS PAC ID: 3678600988 Enrollment ID: O20100419000408 |
News Archive
Huntington's disease (HD) is a fatal hereditary disease for which there is no cure. A novel study from Cedars-Sinai Medical Center, Los Angeles, using pluripotent stem cells advances understanding of how the disease develops and may help pave the way for identifying pathways for future treatments.
Barr Pharmaceuticals, Inc. has announced that the U.S. District Court for the District of New Jersey has ruled in favor of its subsidiary, Barr Laboratories, Inc., in the challenge of the patent listed by Bayer Schering Pharma, AG in connection with Bayer Schering's Yasmin(R) (drospirenone and ethinyl estradiol) oral contraceptive.
JP Errico, founder and CEO of electroCore, speaking at The FT Global Pharmaceutical and Biotechnology Conference in London last week, emphasized the importance of working with each of the major stakeholders, i.e., patients and their advocates, key opinion-leading physicians, and decision-makers within the payor community at the earliest opportunity, particularly in regards to innovative and disruptive technology such as electroCore's non-invasive vagus nerve stimulation (nVNS).
A study on the effects of donepezil on people with mild to moderate Alzheimer Disease entitled Long-term donepezil treatment in 565 patients with Alzheimer's Disease(AD2000): randomised double-blind trial appears in the June 26, 2004 issue of The Lancet.
University of Maryland School of Nursing researchers say nurses in hospitals and other health care facilities may perform better by following the lead of airlines, trucking, and nuclear plants, by limiting hours of service, ensuring prompt and definite breaks during shifts, and other scheduling strategies.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amir Habib, MD 250 N Shadeland Ave, Indianapolis, IN 46219-4959 Ph: () - | Amir Habib, MD 3500 S Lafountain St, Kokomo, IN 46902-3803 Ph: (765) 453-8090 |
News Archive
Huntington's disease (HD) is a fatal hereditary disease for which there is no cure. A novel study from Cedars-Sinai Medical Center, Los Angeles, using pluripotent stem cells advances understanding of how the disease develops and may help pave the way for identifying pathways for future treatments.
Barr Pharmaceuticals, Inc. has announced that the U.S. District Court for the District of New Jersey has ruled in favor of its subsidiary, Barr Laboratories, Inc., in the challenge of the patent listed by Bayer Schering Pharma, AG in connection with Bayer Schering's Yasmin(R) (drospirenone and ethinyl estradiol) oral contraceptive.
JP Errico, founder and CEO of electroCore, speaking at The FT Global Pharmaceutical and Biotechnology Conference in London last week, emphasized the importance of working with each of the major stakeholders, i.e., patients and their advocates, key opinion-leading physicians, and decision-makers within the payor community at the earliest opportunity, particularly in regards to innovative and disruptive technology such as electroCore's non-invasive vagus nerve stimulation (nVNS).
A study on the effects of donepezil on people with mild to moderate Alzheimer Disease entitled Long-term donepezil treatment in 565 patients with Alzheimer's Disease(AD2000): randomised double-blind trial appears in the June 26, 2004 issue of The Lancet.
University of Maryland School of Nursing researchers say nurses in hospitals and other health care facilities may perform better by following the lead of airlines, trucking, and nuclear plants, by limiting hours of service, ensuring prompt and definite breaks during shifts, and other scheduling strategies.
› Verified 7 days ago
Leny Philip, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 3118 S Lafountain St, Kokomo, IN 46902 Phone: 765-864-4160 Fax: 765-864-4166 | |
Dr. Alok Silodia, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2350 S Dixon Rd Ste 430, Kokomo, IN 46902 Phone: 765-453-1205 Fax: 765-453-6889 | |
Huan Cui, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1907 W Sycamore St, Kokomo, IN 46901 Phone: 765-456-5433 | |
Dr. Dawn Marie Sabau, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3508 S Lafountain St, Kokomo, IN 46902 Phone: 765-453-8181 Fax: 765-453-8565 | |
Julie B Tredemeyer, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3611 S Reed Rd Ste 103, Kokomo, IN 46902 Phone: 765-776-5500 | |
Dr. Imran Ahmed Sethi, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1907 W Sycamore St, Kokomo, IN 46901 Phone: 765-456-5847 | |
Karthik Rao Polsani, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3500 S Lafountain St, Kokomo, IN 46902 Phone: 765-776-3020 Fax: 775-453-8111 |